DE69907252D1 - Pharmazeutische kombinationspräparate in fester form enthaltend carvedilol und hydrochlorothiazid - Google Patents

Pharmazeutische kombinationspräparate in fester form enthaltend carvedilol und hydrochlorothiazid

Info

Publication number
DE69907252D1
DE69907252D1 DE69907252T DE69907252T DE69907252D1 DE 69907252 D1 DE69907252 D1 DE 69907252D1 DE 69907252 T DE69907252 T DE 69907252T DE 69907252 T DE69907252 T DE 69907252T DE 69907252 D1 DE69907252 D1 DE 69907252D1
Authority
DE
Germany
Prior art keywords
preparates
hydrochlorothiazide
solid form
pharmaceutical combination
form containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69907252T
Other languages
English (en)
Other versions
DE69907252T2 (de
Inventor
Rudolf Heller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8233041&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69907252(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE69907252D1 publication Critical patent/DE69907252D1/de
Application granted granted Critical
Publication of DE69907252T2 publication Critical patent/DE69907252T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DE69907252T 1998-11-27 1999-11-20 Pharmazeutische kombinationspräparate in fester form enthaltend carvedilol und hydrochlorothiazid Expired - Lifetime DE69907252T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98122489 1998-11-27
PCT/EP1999/008972 WO2000032174A2 (en) 1998-11-27 1999-11-20 Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide

Publications (2)

Publication Number Publication Date
DE69907252D1 true DE69907252D1 (de) 2003-05-28
DE69907252T2 DE69907252T2 (de) 2004-01-29

Family

ID=8233041

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69907252T Expired - Lifetime DE69907252T2 (de) 1998-11-27 1999-11-20 Pharmazeutische kombinationspräparate in fester form enthaltend carvedilol und hydrochlorothiazid

Country Status (22)

Country Link
US (3) US6403579B1 (de)
EP (1) EP1131072B1 (de)
JP (2) JP2002531395A (de)
KR (1) KR100421347B1 (de)
CN (1) CN1184971C (de)
AR (1) AR020287A1 (de)
AT (1) ATE238056T1 (de)
AU (1) AU765977B2 (de)
BR (1) BR9915610A (de)
CA (1) CA2352361C (de)
CO (1) CO5011053A1 (de)
DE (1) DE69907252T2 (de)
DK (1) DK1131072T3 (de)
ES (1) ES2195638T3 (de)
MY (1) MY121831A (de)
PE (1) PE20001302A1 (de)
PT (1) PT1131072E (de)
TR (3) TR200101470T2 (de)
TW (1) TWI228414B (de)
UY (1) UY25821A1 (de)
WO (1) WO2000032174A2 (de)
ZA (1) ZA200104280B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
EP1335707A4 (de) * 2000-10-24 2005-07-06 Smithkline Beecham Corp Neue carvedilol-formulierungen
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
IN191028B (de) * 2001-05-17 2003-09-13 Sun Pharmaceutical Ind Ltd
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
CA2483054A1 (en) * 2002-04-30 2003-11-13 Sb Pharmco Puerto Rico Inc. Carvedilol monocitrate monohydrate
WO2004002472A1 (en) 2002-06-27 2004-01-08 Sb Pharmco Puerto Rico Inc. Carvedilol hydrobromide
CN103333099A (zh) 2002-06-27 2013-10-02 史密斯克莱.比奇曼（科克）有限公司 卡维地洛磷酸盐和/或其溶剂合物相应的组合物和/或治疗方法
US20040151772A1 (en) 2002-11-08 2004-08-05 Egalet A/S Controlled release carvedilol compositions
EP1610767B1 (de) 2003-03-26 2011-01-19 Egalet A/S Morphin-system mit kontrollierter freisetzung
EP1615888A1 (de) * 2003-04-21 2006-01-18 Matrix Laboratories Ltd Verfahren zur herstellung von carvedilol form-ii
AU2003272851A1 (en) * 2003-09-26 2005-04-14 Shuyi Zhang Sustained release preparation containing hydrochlorothiazide
WO2005051383A1 (en) 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
US20050169994A1 (en) * 2003-11-25 2005-08-04 Burke Matthew D. Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
WO2005051322A2 (en) * 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts
SI1691804T1 (sl) * 2003-12-02 2007-10-31 Nicox Sa Nitrooksi derivati karvedilola in drugih beta blokatorjev kot antihipertenzivi
EP1855655A2 (de) * 2005-02-25 2007-11-21 F. Hoffmann-Roche AG Tabletten mit verbesserter dispergierbarkeit der arzneisubstanz
US8685452B2 (en) * 2006-06-16 2014-04-01 Lek Pharmaceuticals D.D. Pharmaceutical composition
GB0612540D0 (en) * 2006-06-23 2006-08-02 Novartis Ag Galenical formulations of organic compounds
WO2008114276A1 (en) * 2007-03-16 2008-09-25 Lupin Limited Novel oral controlled release composition of carvedilol
CA2687192C (en) 2007-06-04 2015-11-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
WO2010089132A1 (en) 2009-02-06 2010-08-12 Egalet A/S Immediate release composition resistant to abuse by intake of alcohol
EP2445487A2 (de) 2009-06-24 2012-05-02 Egalet Ltd. Retard-formulierungen
US20130121916A1 (en) * 2010-03-10 2013-05-16 Sergio Baroni Compositions for Colon Lavage and Methods of Making and Using Same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2643556B1 (fr) * 1989-02-27 1993-03-05 Sanofi Sa Composition pharmaceutique a liberation prolongee d'acide valproique
GB2257363B (en) * 1991-01-30 1994-09-28 Wellcome Found Water dispersible tablets containing acyclovir
ES2106818T3 (es) * 1991-10-30 1997-11-16 Glaxo Group Ltd Composicion multicapa que contiene antagonistas de histamina o secotina.
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
US5760069A (en) * 1995-02-08 1998-06-02 Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 Method of treatment for decreasing mortality resulting from congestive heart failure
FR2752162B1 (fr) * 1996-08-07 1998-11-06 Jouveinal Lab Comprime de maleate de trimebutine pellicule
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida

Also Published As

Publication number Publication date
DE69907252T2 (de) 2004-01-29
TR200101470T2 (tr) 2001-11-21
ES2195638T3 (es) 2003-12-01
KR100421347B1 (ko) 2004-03-06
ZA200104280B (en) 2002-08-26
PT1131072E (pt) 2003-08-29
JP2007077160A (ja) 2007-03-29
TWI228414B (en) 2005-03-01
BR9915610A (pt) 2001-08-14
CO5011053A1 (es) 2001-02-28
UY25821A1 (es) 2001-07-31
AR020287A1 (es) 2002-05-02
DK1131072T3 (da) 2003-08-11
AU765977B2 (en) 2003-10-09
WO2000032174A3 (en) 2000-11-16
US20040087578A1 (en) 2004-05-06
CN1328460A (zh) 2001-12-26
US6403579B1 (en) 2002-06-11
WO2000032174A2 (en) 2000-06-08
PE20001302A1 (es) 2000-11-30
CA2352361C (en) 2007-01-02
TR200200981T2 (tr) 2002-06-21
TR200200982T2 (tr) 2002-06-21
CA2352361A1 (en) 2000-06-08
CN1184971C (zh) 2005-01-19
US20020052367A1 (en) 2002-05-02
EP1131072B1 (de) 2003-04-23
JP2002531395A (ja) 2002-09-24
AU1506500A (en) 2000-06-19
MY121831A (en) 2006-02-28
ATE238056T1 (de) 2003-05-15
KR20010080578A (ko) 2001-08-22
EP1131072A2 (de) 2001-09-12

Similar Documents

Publication Publication Date Title
DE69907252T2 (de) Pharmazeutische kombinationspräparate in fester form enthaltend carvedilol und hydrochlorothiazid
DE69739642D1 (de) Feste orale Dosierungsformen enthaltend Valsartan und Hydrochlorothiazide
CY2013032I2 (el) Συζυγη της εξενδινης-4 και η φαρμακευτικη τους χρηση
DE60138768D1 (de) Glucopyranosylpyrazolderivate und deren verwendung in arzneimitteln
CY2009015I2 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
PT1212317E (pt) Derivados de indole e sua utilizacao no tratamento de osteoporose entre outras aplicacoes
EE04566B1 (et) Epotilooni derivaadid ja nende kasutamine meditsiinis
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
EE05210B1 (et) Suhkurt?vevastane preparaat ja selle kasutamine meditsiinis
DE60042576D1 (de) Arbeitseinheit und Bilderzeugungsgerät
DE69930033D1 (de) Wasserlösliches Hedgehog-Protein im ionischen Komplex und deren pharmazeutische Verwendung
EE200000723A (et) Asendatud indolinoonid, nende valmistamine ja nende kasutamine ravimitena
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
DE69704060D1 (de) Tetrahydroisochinolinderivate und ihre pharmazeutische anwendung
DE69840934D1 (de) Bildgebungsvorrichtung und zahnärtzliche einheit
HUP0203121A3 (en) Pharmaceutical composition containing substituted benzimidazoles and its use
ATE310726T1 (de) Pyridin-derivate und diese enthaltende pharmazeutische mittel
DE69809928T2 (de) Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen
DE69907735D1 (de) Melatoninderivate und diese enthaltende pharmazeutische zubereitung
ITFI970072A0 (it) Composti pseudo-peptidici, loro preparazione ed uso in formulazioni farmaceutiche
DE69813624D1 (de) Gemisch und pharmazeutische zubereitung enthaltend z-4-hydroxytamoxifen und cyclodextrin
DE60034963D1 (de) Heterocyclische derivate und arzneistoffe
ATE279927T1 (de) Pharmazeutische zusammensetzungen enthaltend tobramycin und xanthangummi
ATE338548T1 (de) Pyridoindolonderivate und antikrebsmittel enthaltende pharmazeutische mischungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition